Education
About Us
Working with TipRanks
Follow Us
BioLargo Inc (BLGO)
OTHER OTC:BLGO
Total Valuation
BioLargo has a market cap or net worth of $49.05M. The enterprise value is $59.84M.
Market Cap$49.05M
Enterprise Value$59.84M
Share Statistics
BioLargo has 308,989,040 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding308,989,040
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioLargo’s return on equity (ROE) is -0.27 and return on invested capital (ROIC) is -91.03%.
Return on Equity (ROE)-0.27
Return on Assets (ROA)-0.23
Return on Invested Capital (ROIC)-91.03%
Return on Capital Employed (ROCE)-0.55
Revenue Per Employee444.48K
Profits Per Employee-108.67K
Employee Count40
Asset Turnover1.69
Inventory Turnover30.08
Valuation Ratios
The current PE Ratio of BioLargo is ―. BioLargo’s PEG ratio is 0.69.
PE Ratio―
PS Ratio3.19
PB Ratio6.40
Price to Fair Value6.40
Price to FCF-12.75
Price to Operating Cash Flow-6.45
PEG Ratio0.69
Income Statement
In the last 12 months, BioLargo had revenue of 17.78M and earned -2.40M in profits. Earnings per share was -0.01.
Revenue17.78M
Gross Profit7.85M
Operating Income-4.33M
Pretax Income-2.40M
Net Income-2.40M
EBITDA-4.06M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -8.62M and capital expenditures 25.00K, giving a free cash flow of -8.60M billion.
Operating Cash Flow-8.62M
Free Cash Flow-8.60M
Free Cash Flow per Share-0.03
Dividends & Yields
BioLargo pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.40
52-Week Price Change-12.50%
50-Day Moving Average0.17
200-Day Moving Average0.21
Relative Strength Index (RSI)54.18
Average Volume (3m)570.01K
Important Dates
BioLargo upcoming earnings date is Apr 6, 2026, TBA (Confirmed).
Last Earnings DateNov 17, 2025
Next Earnings DateApr 6, 2026
Ex-Dividend Date―
Financial Position
BioLargo as a current ratio of 2.70, with Debt / Equity ratio of 22.71%
Current Ratio2.70
Quick Ratio2.57
Debt to Market Cap0.02
Net Debt to EBITDA0.24
Interest Coverage Ratio-31.16
Taxes
In the past 12 months, BioLargo has paid 1.95M in taxes.
Income Tax1.95M
Effective Tax Rate-0.81
Enterprise Valuation
BioLargo EV to EBITDA ratio is -13.71, with an EV/FCF ratio of -12.53.
EV to Sales3.13
EV to EBITDA-13.71
EV to Free Cash Flow-12.53
EV to Operating Cash Flow-17.36
Balance Sheet
BioLargo has $4.55M in cash and marketable securities with $1.49M in debt, giving a net cash position of $3.05M billion.
Cash & Marketable Securities$4.55M
Total Debt$1.49M
Net Cash$3.05M
Net Cash Per Share<$0.01
Tangible Book Value Per Share$0.02
Margins
Gross margin is 46.56%, with operating margin of -24.36%, and net profit margin of -13.51%.
Gross Margin46.56%
Operating Margin-24.36%
Pretax Margin-13.51%
Net Profit Margin-13.51%
EBITDA Margin-22.83%
EBIT Margin-24.26%
Analyst Forecast
The average price target for BioLargo is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-41.57%
EPS Growth Forecast-345.83%